Showing results (61-70 of 237) with videos related to

Sort By:
Pageof 24
Breast Cancer : Basic and Clinical Research|November 26, 2024
The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report With Transbronchial Lung CryobiopsyShota Kaburaki, Toru Tanaka, Akari Murata, et al.
Pulmonary Circulation|August 22, 2024
Novel evaluation of pulmonary hypertension associated with chronic lung disease using perfusion SPECT/CT: A pilot studyKenichiro Atsumi, Yoshimitsu Fukushima, Yosuke Tanaka, et al.
Cancer Research|August 9, 2003
Proteomic analysis of intestinal epithelial cells expressing stabilized beta-cateninMasahiro Seike, Tadashi Kondo, Yasuharu Mori, et al.
The Journal of Dermatological Treatment|November 11, 2024
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsyShota Kaburaki, Naoko Okada, Toru Tanaka, et al.
Respiratory Medicine Case Reports|July 19, 2024
Evaluation of sarcoidosis with multiple bone lesions using both bone scintigraphy and FDG-PET/CT: A case reportNaohiro Kadoma, Kenichiro Atsumi, Kaoruko Shinbu, et al.
Respiratory Medicine|March 30, 2025
Pulse corticosteroid therapy in interstitial lung disease-associated with anti-aminoacyl-tRNA synthetase antibodies: Comparable efficacy with potential for reduced adverse eventsShota Kaburaki, Toru Tanaka, Koichiro Kamio, et al.
Oncotargets and Therapy|March 24, 2025
Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric StudyHirokazu Iso, Makiko Yomota, Yukari Shirakura, et al.
Anticancer Research|January 30, 2022
A Novel Molecular Target in <i>EGFR</i>-mutant Lung Cancer Treated With the Combination of Osimertinib and PemetrexedNatsuki Takano, Masahiro Seike, Teppei Sugano, et al.
Cancer Medicine|September 11, 2023
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancerTakehiro Tozuka, Rintaro Noro, Akihiko Miyanaga, et al.
Journal of Cancer Research and Clinical Oncology|July 13, 2023
Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective studyTomoyuki Naito, Yuji Minegishi, Hideaki Shiraishi, et al.
Pageof 24